CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
CVRx, a medical device company specializing in neuromodulation solutions for cardiovascular diseases, will present at the Goldman Sachs 47th Annual Global Healthcare Conference. The company highlighted its FDA-approved Barostim device, which treats heart failure by neuromodulation and has regulatory approvals in both the U.S. and Europe.